SCHEMBL30872174

SCHEMBL30872174

Cc1cc(C)nc(-n2cc3c(c2)CN(C(=O)c2c(-c4ccc(C)s4)cn4ccccc24)C3)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 12/20 0.35
HCRTR2 O43614 12/20 0.35
KDM4E B2RXH2 6/20 0.34
ALDH1A1 P00352 6/20 0.34
KMT2A Q03164 5/20 0.34
MEN1 O00255 4/20 0.34
GAA P10253 3/20 0.34
HPGD P15428 3/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
MAPT P10636 5/20 0.33
POLB P06746 2/20 0.33
ATM Q13315 2/20 0.33
LMNA P02545 1/20 0.33
PPARG P37231 1/20 0.33
NCOA2 Q15596 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30872176 0.87 KDM4E (0.47) HCRTR1HCRTR2KDM4EALDH1A1KMT2A
SCHEMBL30872186 0.84 HCRTR1 (0.45) HCRTR1HCRTR2KDM4EALDH1A1KMT2A
SCHEMBL30872161 0.83 HCRTR1 (0.48) HCRTR1HCRTR2
SCHEMBL30997247 0.83 HCRTR1 (0.55) HCRTR1HCRTR2
SCHEMBL30872171 0.81 HCRTR1 (0.50) HCRTR1HCRTR2
SCHEMBL30872184 0.79 HCRTR1 (0.43) HCRTR1HCRTR2POLB
SCHEMBL30872180 0.70 HCRTR1 (0.43) HCRTR1HCRTR2
SCHEMBL30872178 0.70 HCRTR1 (0.67) HCRTR1HCRTR2
SCHEMBL31351491 0.69 HCRTR2 (0.65) HCRTR1HCRTR2
SCHEMBL30872167 0.68 HCRTR1 (0.64) HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024109672-A1 DISUBSTITUTED OCTAHYDROPYRROLO[3,4-C]PYRROLE METHYL KETONE DERIVATIVE AND APPLICATION THEREOF 江苏恩华药业股份有限公司 2024-05-30 WO disclosed